Antimicrobial peptides: Agents of border protection for companion animals

Veterinary Dermatology

Volumn 23, Issue 3, 2012, Pages

  Leonard, Brian C ^a   Affolter, Verena K ^b   Bevins, Charles L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CATHELICIDIN; DEFENSIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; BACTERIAL INFECTION; CHEMOTAXIS; DOG; HAIR COLOR; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSORIASIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CATHELICIDINS; CHEMOTAXIS; DEFENSINS; DERMATITIS, ATOPIC; DOGS; HAIR COLOR; HUMANS; PSORIASIS;

ANIMALIA;

EID: 84860919935     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01037.x     Document Type: Article

References (96)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
2. Yang D, Chertov O, Bykovskaia SN et al. Beta-defensins: linking innate and adaptive immunity through dendritic and Tcell CCR6. Science 1999; 286: 525-528.
3. Frohm M, Gunne H, Bergman AC et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 1996; 237: 86-92.
4. Candille SI, Kaelin CB, Cattanach BM et al. A β-defensin mutation causes black coat color in domestic dogs. Science 2007; 318: 1418-1423.
5. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720.
6. Wingate KV, Torres SM, Silverstein KA et al. Expression of endogenous antimicrobial peptides in normal canine skin. Vet Dermatol 2009; 20: 19-26.
7. Leonard BC, Chu H, Johns JL et al. Expression and activity of a novel cathelicidin from domestic cats. PLoS ONE 2011; 6: e18756.
8. Borkowski AW, Gallo RL. The coordinated response of the physical and antimicrobial peptide barriers of the skin. J Invest Dermatol 2011; 131: 285-287.
9. Saito T, Kawabata S, Shigenaga T et al. A novel big defensin identified in horseshoe crab hemocytes: isolation, amino acid sequence, and antibacterial activity. J Biochem 1995; 117: 1131-1137.
10. Patil AA, Cai Y, Sang Y et al. Cross-species analysis of the mammalian β-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. Physiol Genomics 2005; 23: 5-17.
11. Patil A, Hughes AL, Zhang G. Rapid evolution and diversification of mammalian α-defensins as revealed by comparative analysis of rodent and primate genes. Physiol Genomics 2004; 20: 1-11.
12. Tang YQ, Yuan J, Osapay G et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 1999; 286: 498-502.
13. Zanetti M. The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 2005; 7: 179-196.
14. Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995; 374: 1-5.
15. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75: 39-48.
16. Sang Y, Teresa Ortega M, Rune K et al. Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide. Dev Comp Immunol 2007; 31: 1278-1296.
17. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008; 122: 261-266.
18. Ali RS, Falconer A, Ikram M et al. Expression of the peptide antibiotics human β defensin-1 and human β defensin-2 in normal human skin. J Invest Dermatol 2001; 117: 106-111.
19. Harder J, Bartels J, Christophers E et al. A peptide antibiotic from human skin. Nature 1997; 387: 861.
20. Harder J, Bartels J, Christophers E et al. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707-5713.
21. O'Neil DA, Porter EM, Elewaut D et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163: 6718-6724.
22. Bensch KW, Raida M, Mägert HJ et al. hBD-1: a novel β-defensin from human plasma. FEBS Lett 1995; 368: 331-335.
23. Valore EV, Park CH, Quayle AJ et al. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101: 1633-1642.
24. Liu L, Zhao C, Heng HH et al. The human β-defensin-1 and α-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 1997; 43: 316-320.
25. Liu L, Wang L, Jia HP et al. Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 1998; 222: 237-244.
26. Wolk K, Kunz S, Witte E et al. IL-22 increases the innate immunity of tissues. Immunity 2004; 21: 241-254.
27. Kao CY, Kim C, Huang F et al. Requirements for two proximal NF-κB binding sites and IκB-ζ in IL-17A-induced human β-defensin 2 expression by conducting airway epithelium. J Biol Chem 2008; 283: 15309-15318.
28. Harder G, McGowan R. Isolation and characterization of the muscle-specific isoform of creatine kinase from the zebrafish, Danio rerio. Biochem Cell Biol 2001; 79: 779-782.
29. Sang Y, Ortega MT, Blecha F et al. Molecular cloning and characterization of three β-defensins from canine testes. Infect Immun 2005; 73: 2611-2620.
30. van Damme CM, Willemse T, van Dijk A et al. Altered cutaneous expression of β-defensins in dogs with atopic dermatitis. Mol Immunol 2009; 46: 2449-2455.
31. Santoro D, Bunick D, Graves TK et al. Expression and distribution of antimicrobial peptides in the skin of healthy beagles. Vet Dermatol 2010; 22: 61-67.
32. Erles K, Brownlie J. Expression of β-defensins in the canine respiratory tract and antimicrobial activity against Bordetella bronchiseptica. Vet Immunol Immunopathol 2010; 135: 12-19.
33. Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 1995; 368: 173-176.
34. Schauber J, Dorschner RA, Yamasaki K et al. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 2006; 118: 509-519.
35. Liu PT, Stenger S, Tang DH et al. Cutting edge: vitaminD-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179: 2060-2063.
36. Yuk JM, Shin DM, Lee HM et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6: 231-243.
37. 3. FASEB J 2005; 19: 1067-1077.
38. Fujii G, Selsted ME, Eisenberg D. Defensins promote fusion and lysis of negatively charged membranes. Protein Sci 1993; 2: 1301-1312.
39. Wimley WC, Selsted ME, White SH. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci 1994; 3: 1362-1373.
40. Lehrer RI, Barton A, Daher KA et al. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989; 84: 553-561.
41. Wei G, de Leeuw E, Pazgier M et al. Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem 2009; 284: 29180-29192.
42. Schneider T, Kruse T, Wimmer R et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor LipidII. Science 2010; 328: 1168-1172.
43. de Leeuw E, Li C, Zeng P et al. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipidII. FEBS Lett 2010; 584: 1543-1548.
44. Sass V, Schneider T, Wilmes M et al. Human β-defensin3 inhibits cell wall biosynthesis in staphylococci. Infect Immun 2010; 78: 2793-2800.
45. Fazakerley J, Crossley J, McEwan N et al. In vitro antimicrobial efficacy of β-defensin3 against Staphylococcus pseudintermedius isolates from healthy and atopic canine skin. Vet Dermatol 2010; 21: 463-468.
46. Schmidtchen A, Frick IM, Andersson E et al. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 2002; 46: 157-168.
47. 2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem 2004; 279: 52820-52823.
48. Sieprawska-Lupa M, Mydel P, Krawczyk K et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 2004; 48: 4673-4679.
49. Maemoto A, Qu X, Rosengren KJ et al. Functional analysis of the α-defensin disulfide array in mouse cryptdin-4. J Biol Chem 2004; 279: 44188-44196.
50. Jin T, Bokarewa M, Foster T et al. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004; 172: 1169-1176.
51. Fernie-King BA, Seilly DJ, Lachmann PJ. The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. Immunology 2004; 111: 444-452.
52. Guo L, Lim KB, Poduje CM et al. LipidA acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998; 95: 189-198.
53. Peschel A, Otto M, Jack RW et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999; 274: 8405-8410.
54. Kristian SA, Datta V, Weidenmaier C et al. d-Alanylation of teichoic acids promotes groupA streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol 2005; 187: 6719-6725.
55. Staubitz P, Neumann H, Schneider T et al. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett 2004; 231: 67-71.
56. Nishi H, Komatsuzawa H, Fujiwara T et al. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother 2004; 48: 4800-4807.
57. Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 2009; 30: 131-141.
58. Territo MC, Ganz T, Selsted ME et al. Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 1989; 84: 2017-2020.
59. Chertov O, Michiel DF, Xu L et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996; 271: 2935-2940.
60. Yang D, Chen Q, Chertov O et al. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 2000; 68: 9-14.
61. Rohrl J, Yang D, Oppenheim JJ et al. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J Biol Chem 2010; 285: 7028-7034.
62. Taylor K, Clarke DJ, McCullough B et al. Analysis and separation of residues important for the chemoattractant and antimicrobial activities of β-defensin3. J Biol Chem 2008; 283: 6631-6639.
63. 2 is essential for chemoattractant activity of β-defensin Defb14 through chemokine receptor6. Mol Immunol 2010; 47: 1378-1382.
64. Rohrl J, Yang D, Oppenheim JJ et al. Identification and biological characterization of mouse β-defensin14, the orthologue of human β-defensin3. J Biol Chem 2008; 283: 5414-5419.
65. Rohrl J, Yang D, Oppenheim JJ et al. Human β-defensin2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 2010; 184: 6688-6694.
66. Chhajlani V, Wikberg JE. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992; 309: 417-420.
67. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992; 71: 1195-1204.
68. Ollmann MM, Lamoreux ML, Wilson BD et al. Interaction of Agouti protein with the melanocortin1 receptor in vitro and in vivo. Genes Dev 1998; 12: 316-330.
69. Slominski A, Plonka PM, Pisarchik A et al. Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. Endocrinology 2005; 146: 1245-1253.
70. Barsh GS. Regulation of pigment type switching by Agouti. In: Nordlund JJ, Boissy RE, Hearing VJ et al. eds. The Pigmentary System, 2nd edition. Oxford: Blackwell, 2006: 395-410.
71. Little CC. The Inheritance of Coat Color in Dogs. New York: Howell Book House, 1957: 49-68.
72. Kerns JA, Olivier M, Lust G et al. Exclusion of Melanocortin-1 receptor (mc1r) and agouti as candidates for dominant black in dogs. J Hered 2003; 94: 75-79.
73. Kerns JA, Cargill EJ, Clark LA et al. Linkage and segregation analysis of black and brindle coat color in domestic dogs. Genetics 2007; 176: 1679-1689.
74. Yudin AI, Tollner TL, Li MW et al. ESP13.2, a member of the β-defensin family, is a macaque sperm surface-coating protein involved in the capacitation process. Biol Reprod 2003; 69: 1118-1128.
75. Yudin AI, Tollner TL, Treece CA et al. β-Defensin22 is a major component of the mouse sperm glycocalyx. Reproduction 2008; 136: 753-765.
76. Zhao Y, Diao H, Ni Z et al. The epididymis-specific antimicrobial peptide β-defensin15 is required for sperm motility and male fertility in the rat (Rattus norvegicus). Cell Mol Life Sci 2011; 68: 697-708.
77. Tollner TL, Yudin AI, Tarantal AF et al. Beta-defensin126 on the surface of macaque sperm mediates attachment of sperm to oviductal epithelia. Biol Reprod 2008; 78: 400-412.
78. Tollner TL, Yudin AI, Treece CA et al. Macaque sperm coating protein DEFB126 facilitates sperm penetration of cervical mucus. Hum Reprod 2008; 23: 2523-2534.
79. Tollner TL, Venners SA, Hollox EJ et al. A common mutation in the defensin DEFB126 causes impaired sperm function and subfertility. Sci Transl Med 2011; 3: 92ra65.
80. Beckmann JS, Estivill X, Antonarakis SE. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 2007; 8: 639-646.
81. Nicholas TJ, Cheng Z, Ventura M et al. The genomic architecture of segmental duplications and associated copy number variants in dogs. Genome Res 2009; 19: 491-499.
82. Linzmeier RM, Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in α- and β-defensin regions at 8p22-p23. Genomics 2005; 86: 423-430.
83. Hollox EJ. Copy number variation of β-defensins and relevance to disease. Cytogenet Genome Res 2008; 123: 148-155.
84. Chen WK, Swartz JD, Rush LJ et al. Mapping DNA structural variation in dogs. Genome Res 2009; 19: 500-509.
85. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
86. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
87. Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564-569.
88. Hollox EJ, Huffmeier U, Zeeuwen PL et al. Psoriasis is associated with increased β-defensin genomic copy number. Nat Genet 2008; 40: 23-25.
89. Feijen M, Gerritsen J, Postma DS. Genetics of allergic disease. Br Med Bull 2000; 56: 894-907.
90. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25: 522-529.
91. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Vet Immunol Immunopathol 2001; 81: 147-151.
92. Marsella R, Girolomoni G. Canine models of atopic dermatitis: a useful tool with untapped potential. J Invest Dermatol 2009; 129: 2351-2357.
93. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105: 860-876.
94. Nomura I, Goleva E, Howell MD et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003; 171: 3262-3269.
95. Kisich KO, Carspecken CW, Fiéve S et al. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3. J Allergy Clin Immunol 2008; 122: 62-68.
96. Harder J, Dressel S, Wittersheim M et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010; 130: 1355-1364.